Article info

Download PDFPDF
Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro

Authors

  1. Correspondence to Professor Yoshiya Tanaka, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8555, Japan; tanaka{at}med.uoeh-u.ac.jp
View Full Text

Citation

Wang S, Iwata S, Nakayamada S, et al
Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro

Publication history

  • Received March 23, 2014
  • Revised August 8, 2014
  • Accepted August 10, 2014
  • First published August 25, 2014.
Online issue publication 
October 30, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.